drugset / Trial / NCT00492479

An Evaluation of Kinerase Pro+Therapy Regimen Vs. Kinerase Vs. Control for the Treatment of Skin Aging

NCT00492479 ↗

Phase 4 Terminated Innovative Medical
RandomizedParallel-groupSingle-blind

Summary

The purpose of this study is to compare the efficacy of the Kinerase Pro+Therapy regimen versus a single Kinerase product vs. control for the treatment of the signs of skin aging.

Timeline

Start
2007-06
Primary completion
—
Completion
2007-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Kinerase Pro+Therapy Line Ultra rich day repair Unknown — —
Subject Kinerase Pro+Therapy Line day repair, serum, night repair Unknown — —
Subject LubriDerm Unknown — —

Indications